Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies 
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics 
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power 
Leapmotor Targets 4 Million Annual EV Sales as Global Expansion Accelerates 
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares 
China’s Iron Ore Buyer Pressures Mining Giants as New Supply Shifts Market Power 
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel 
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market 
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China 
Vietnam’s EV Taxi Giant GSM Eyes Hong Kong IPO With $2–3 Billion Valuation 
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round 
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital 
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro 
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms 
Trump Administration Probes Corporate DEI Programs, Raising Questions for Google Stock 
Lockheed Martin Secures $92.8M AEGIS Sustainment Contract from U.S. Navy 
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts 
Proven technology leader to play key role at fast-growing pharmaceutical services firm
|
|||||
PRINCETON, N.J., March 14, 2016 -- APCER Life Sciences, the truly global provider of safety, medical, regulatory, and technology services, announced today that Ms. Aparna Mazumdar has joined the firm as Head of Global Business Solutions. Aparna will lead the development and implementation of technology-based solutions for APCER’s expanding offices and rapidly growing client base.
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/4061d734-3a14-471e-b850-b6d3287f548f
“We are taking major steps to enhance our information technology and business solutions through significant investments in talent, processes, and assets,” said Suneet Walia, President and CEO of APCER Life Sciences, Inc. “We are pleased to welcome Aparna, a proven technology leader in the pharmaceutical industry, to play a key role in the next phase of our journey.”
Aparna has more than fifteen years’ experience in managing IT organizations and executing enterprise level projects. She worked for twelve years at Sun Pharma in positions of increasing responsibility and was most recently the Global Head of R&D IT at Sun Pharmaceutical Industries Ltd. Prior to that, Aparna worked with Pentasoft Technologies Ltd. as Project Manager & Faculty. She also has three years of research experience.
“APCER has a bold plan to develop products and services that maximize efficiencies and compliance,” said Aparna Mazumdar. “I’m excited to apply the experience I’ve gained inside a dynamic pharmaceutical company to deliver solutions that will provide benefits across the global marketplace.”
Aparna holds a Master of Life Sciences degree from DAVV Indore, a Master of Biotechnology and Engineering from India Institute of Technology Kharagpur, one of India’s most prestigious technical universities, and a Master of Business Administration with specialization in Strategic Management and Information Technology from Management Development Institute, a premier business school in Gurgaon, India.
Aparna will be based in APCER’s Delhi, India office and lead a global team located in Delhi and London, UK.
About APCER Life Sciences
APCER Life Sciences is committed to improving health in partnership with its clients. It brings together safety, medical, regulatory, and technology resources from around the world to ensure that patients receive the safest, most effective therapies possible.
To learn how APCER Life Sciences works together for better health, please follow the company on Twitter, LinkedIn, and Facebook; visit www.apcerls.com; and contact APCER at one of their global offices.
Jill Notte APCER Life Sciences 609-436-4714
